Tengelmann Ventures, which previously took part in the digital wealth manager’s series A round last year, has returned for a $33.5m series B.
Month: June 2017
Syntimmune sinks $50m in series B round
Baxalta-backed Syntimmune has raised $50m in an Apple Tree Partners-led series B round that will fund clinical development of its autoimmune diseases treatment.
Mswipe charges to $31m
Ola-backed Mswipe has secured funding in a series C round that enabled another strategic investor, Axis Bank, to exit.
Buildout structures $8m series A
Susquehanna Growth Equity supplied all of the funding, which real estate marketing platform Buildout will use to almost double its 30-strong team.
Augury activates $17m series B
Industrial internet-of-things technology developer Augury has now raised $26m altogether, after Munich Re/HSB Ventures co-led its latest round.
Bigger bags $18m
Hongfu Group has led a series A round for Bigger, a green co-working spinout of Modern Land, investing alongside First Care.
Maif invests to gets Rythm
Sleep aid developer Rythm has disclosed $22m of funding from investors including insurance company Maif, about $11m of which it has secured since early 2016.
Novartis helps transplant $40m into Gamida
Gamida Cell has raised new funding from a consortium including Novartis, a shareholder since 2014 when it invested $35m in the cellular therapy developer.
Sanovas performs $75m fundraising
Sanovas has signed an agreement with the government of Suzhou in China to create a $75m fund and innovation centre at the Chinese Academy of Sciences.
FuboTV channels $55m for series C
Scripps Networks Interactive and existing backers 21st Century Fox and Sky all participated in a Northzone-led round that will be used to expand FuboTV’s range of channels.
Cybereason secures $100m in SoftBank investment
SoftBank has provided $100m for the cybersecurity software producer, about 18 months after investing $50m as part of a $59m series C round.
FTC calls foul on DraftKings/FanDuel merger
The US Federal Trade Commission has joined two US states to seek an injunction blocking the merger of the corporate-backed daily fantasy sports companies.
Ocugen eyes Abdi Ibrahim for series B
The eye disease treatment developer has raised $7.5m in a round co-led by pharmaceutical company Abdi Ibrahim, six months after closing a $6m series A.
Regroup gets $6m together
OSF HealthCare’s corporate venturing unit has led a series A round for mental health telemedicine provider Regroup Therapy.